Novel anti-staphylococcal targets and compounds

Bibliography

• SCHENTAG JJ, HYATT JM, CARR JR et al.: Genesis ofmethicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections was selected for vancomycin-resistant Entercoccus faecium, and the importance of antibiotic management and infection control. Clin. Infect. Dis. (1998) 26:1204–1214.
   PubMed Web of Science ®Google Scholar
• ABRAHAM EP, CHAIN E: An enzyme from bacteria ableto destroy penicillin. Nature (1940) 146:837.
   Google Scholar
• JEVONS MP: Celbenine-resistant staphylococci. Br.Med. J. (1961) 1:124–125.
   Web of Science ®Google Scholar
• VOSS A, DOEBBELING BN: The worldwide prevalence of methicillin resistant Staphylococcus aureus. Int. J. Antimicrob. Agents (1995) 5:101–105.
   PubMed Web of Science ®Google Scholar
• NEU HC: The crisis in antibiotic resistance. Science (1992) 257:1050–1055.
   PubMedGoogle Scholar
• •One of the first reviews emphasising the potential threat of a post-antibiotic era.
   Google Scholar
• VOSS A, MILATOVIC D, WALLRAUCH-SCHWARZ C, ROS-DAHL VT, BRAVENY I: Methicillin-resistant Staphylo-coccus aureus in Europe. Eur. J. Clin. Microbiol. Infect. Dis. (1994) 13:50–55.
   PubMed Web of Science ®Google Scholar
• BOYCE JM: Methicillin-resistant Staphylococcus au-reus: a continuing infection control challenge. Eur. J. Microbiol. Infect. Dis. (1994) 13:45–49.
   PubMed Web of Science ®Google Scholar
• HIRAMATSU K, HANAKI H, INO T et al.: Methicillin-resistant Staphylococcus aureus with reduced vanco-mycin susceptibility. J. Microb. Chemother. (1997) 40:135–146.
   PubMed Web of Science ®Google Scholar
• ••First report on clinical Staphylococcus aureus isolates withreduced susceptibility towards vancomycin (VISA).
   Google Scholar
• BERGER-BACHI B: Insertional inactivation of staphylo-coccal methicillin resistance by Tn551. j Bacteriol. (1983) 154:479–487.
   PubMed Web of Science ®Google Scholar
• DE LENCASTRE H, TOMASZ A: Reassessment of the number of auxiliary genes essential for expression of high-level methicillin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. (1994) 38:2590–2598.
   PubMed Web of Science ®Google Scholar
• MURAKAMI K, TOMASZ A: Involvement of multiple ge-netic determinants in high-level methicillin resistance in Staphylococcus aureus. J. Bacteriol. (1989) 171:874–879.
   PubMed Web of Science ®Google Scholar
• KUHL SH, PATTEE PA, BALDWIN JN: Chromosomal map location of the methicillin resistance determinant in Staphylococcus aureus. J. Bacteriol. (1978) 135:460–465.
   PubMed Web of Science ®Google Scholar
• UBUKATA K, NONOGUCHI R, MATSUHASJI M, KONNO M: Expression and inducibility in Staphylococcus aureus of the mecA gene, which encodes a methicillin-resistant S. aureus specific penicillin-binding protein. Bacteriol. (1989) 171:2882–2885.
   PubMed Web of Science ®Google Scholar
• TESCH W, STRASSLE A, BERGER-BACHI B et al.: Cloning and expression of methicillin resistance from Staphy-lococcus epidermidis in Staphylococcus carnosus. Antimicrob. Agents Chemother. (1988) 32:1494–1499.
   PubMed Web of Science ®Google Scholar
• BECK WD, BERGER-BACHI B, KAYSER FH: Additional DNA in methicillin-resistant Staphylococcus aureus and molecular cloning of mec-specific DNA. J. Bacte-riol. (1986) 165:373–378.
   PubMed Web of Science ®Google Scholar
• MATTHEWS PR, REED KC, STEWART PR: The cloning of chromosomal DNA associated with methicillin and other resistances in Staphylococcus aureus. J. Gen. Mi-crobiol. (1987) 133:1919–1929.
   PubMed Web of Science ®Google Scholar
• HARTMANN BJ, TOMASZ A: Low affinity penicillin bind-ing protein associated with 13-lactam resistance in Staphylococcus aureus. J. Bacteriol. (1984) 158:513–516.
   PubMed Web of Science ®Google Scholar
• BEISE F, LABISCHINSKI H, GIESBRECHT P: Selective inhi-bition of penicillin-binding proteins and its effects on growth and architecture of Staphylococcus aureus. FEMS Microbic)]. Lett. (1988) 55:195–202.
   Web of Science ®Google Scholar
• CHAMBERS HF, SACHDEVA M: Binding of B-lactam anti-biotics to penicillin-binding proteins in methicillin-resistant Staphylococcus aureus. J. Infect. Dis. (1990) 161:1170–1176.
   PubMed Web of Science ®Google Scholar
• WADA A, WATANABE H: Penicillin-binding protein 1 of Staphylococcus aureus is essential for growth. J. Bac-teriol. (1998) 180:2759–2765.
   PubMed Web of Science ®Google Scholar
• PINHO MG, LUDOVICE AM, WU SW, DE LENCASTRE H: Massive reduction in methicillin resistance by trans-poson inactivation of the normal PBP2 in a methicillin-resistant strain of Staphylococcus aureus. Microb. Dru g Resist. Mech. Epidemiol Dis. (1997) 3 :409–413.
   PubMed Web of Science ®Google Scholar
• WU CYE, BLASZCZAK LC, SMITH MC, SKATRUD PL: Con-struction of a modified penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus and purification by immobilized metal affinity chromatog-raphy. J. Bacteriol. (1994) 176:1539–1541.
   PubMed Web of Science ®Google Scholar
• ROYCHOUDHURY S, KAISER RE, BREMS DN, YEH W-K: Specific interaction between 13-lactams and soluble penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus: development of a chromogenic assay. Antimicrob. Agents Chemother. (1996) 40:2075–2079.
   PubMed Web of Science ®Google Scholar
• HANAKI H, AKAGI H, MASURU Y et al.: TOC-39, a novel parenteral broad-spectrum cephalosporin with excel-lent activity against methicillin-resistant Staphylococ-cus aureus. Antimicrob. Agents Chemother. (1995) 39:1120–1126.
   PubMed Web of Science ®Google Scholar
• SUMITA Y, NOUDA H, KANAZAWA K, FUKASAWA M: An-timicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. (1995) 39:910–916.
   PubMed Web of Science ®Google Scholar